Skip to main content

Neuro Central is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • News
  • Topics
    • Care and patient experience
    • Cell biology, pathology and electrophysiology
    • Cognition and psychiatry
    • Drug development
    • Epilepsy and seizure
    • Genetics and gene therapy
    • Imaging and diagnostics
    • Inflammation, immunology and immune disorders
    • Injury, trauma and infection
    • Movement disorders
    • Neurodegeneration and degenerative disease
    • Neuroregeneration and development
    • Oncology and tumor
    • Pain
    • Sleep
    • Stroke
    • Structure and systems neuroscience
    • Technology and techniques

    Follow us on social media

  • Multimedia
    • Videos
    • Infographics
    • Podcasts
    • Webinars

    Follow us on social media

  • Features
    • Our Journals
    • Journal Articles
    • eBooks
    • Opinion
    • Interviews
    • Reports
    • Spotlights
    • In Focus

    Follow us on social media

  • Industry
    • Latest industry news
    • Industry insights

    Follow us on social media

  • Conferences
    • Events Calendar

    Follow us on social media

  • Early Careers
    • Articles & Advice
    • Early Career Expert Panel

    Follow us on social media

  • Register

Welcome to Neuro Central

NEURODEGENERATION AND DEGENERATIVE DISEASE
World Parkinson’s Day: advancing treatment options with cell therapies, gene therapies and novel biologics
CELL BIOLOGY, PATHOLOGY AND ELECTROPHYSIOLOGY
iPSCs shed light into potential target for rare form of ALS
NEURODEGENERATION AND DEGENERATIVE DISEASE
Positive Phase I/II study results for Huntington’s disease gene therapy
IMAGING AND DIAGNOSTICS
Hair strand-based test shows promise for early ALS diagnosis
NEURODEGENERATION AND DEGENERATIVE DISEASE
Two new p-tau assays launched to advance Alzheimer’s research
NEUROREGENERATION AND DEVELOPMENT
Newborns and people with Alzheimer’s share a surprising biomarker
1 / 6

Sign up for our Neuro Central weekly news round-up

CARE AND PATIENT EXPERIENCE / ARTICLE
The importance of a patient-centered approach for treatment-resistant depression
NEURODEGENERATION AND DEGENERATIVE DISEASE / ARTICLE
US FDA approves Alzheimer’s drug donanemab
CARE AND PATIENT EXPERIENCE / ARTICLE
Navigating schizophrenia: a journey from addiction to advocacy

Our Journals

Journal Content

Perspective / Neurodegenerative Disease Management

The link between nutrition and Alzheimer’s disease: from prevention to treatment

Review / CNS Oncology

Adult pilocytic astrocytoma in the molecular era: a comprehensive review

Preliminary Communication / Pain Management

Retrospective analysis on the effect of spinal cord stimulation on opioid consumption

White Paper / Neurodegenerative Disease Management

Living with secondary progressive multiple sclerosis in Europe: perspectives of multiple stakeholders

Review / Pain Management

Transition from acute to chronic pain: where cells, systems and society meet

Review / Pain Management

Abuse-deterrent opioid analgesics: a guide for clinicians

Featured

multiple sclerosis pregnancy
PODCAST
NCTalks with Jan Hillert: pregnancy outcomes in multiple sclerosis
IN FOCUS
Pregnancy outcomes after exposure to interferon beta in MS
CARE AND PATIENT EXPERIENCE / PODCAST
NCTalks with Gavin Giovannoni: advancements in the treatment landscape for multiple sclerosis
IN FOCUS
Multiple sclerosis
IN FOCUS
Pandemic perspectives: COVID-19
SPOTLIGHT
The microbiome
SPOTLIGHT
Antibody therapeutics
IN FOCUS
Inflammation and immunology
INTERVIEWS / PODCAST
Cerebral organoids: past, present and future – Talking Tech News from BioTechniques
SPOTLIGHT
Organoids

Must Watch

NMOSD
CONFERENCES / VIDEO
How inebilizumab addresses key drivers of neuromyelitis optica spectrum disorder: an interview with Prof. Friedemann Paul & Kristina Patterson MD PhD
CARE AND PATIENT EXPERIENCE / VIDEO
MS in the 21st Century (MS21) leads the conversation on COVID-19 vaccination and MS
WEBINAR
The Brain on Drugs: The Strategic Use of Cognitive Measures and Biomarkers in Early-Phase CNS Drug Studies
WEBINAR
Assessing cognition and driving ability: examining simple and cognitive domains in clinical pharmacology studies
INJURY, TRAUMA AND INFECTION / VIDEO
What is next following the FIELD study? An interview with Willie Stewart
INJURY, TRAUMA AND INFECTION / VIDEO
Updates on the BRAIN and HEADING studies: an interview with Neil Pearce
INJURY, TRAUMA AND INFECTION / VIDEO
The Drake Football Study
This is a screenshot of Gavin Giovannoni doing a video interview with Neuro Central on the impact that COVID-19 is having on neurological practice.
CARE AND PATIENT EXPERIENCE / VIDEO
The impact of the COVID-19 pandemic on neurology: an insight from Gavin Giovannoni
This is a video screenshot of Ana Mingorance doing an interview with the Video Journal of Biomedicine.
DRUG DEVELOPMENT / VIDEO
Epilepsy and orphan drug development: an interview with Ana Mingorance
GENETICS AND GENE THERAPY / VIDEO
In Their Own Words with Professor John Hardy
  • About
  • Contact Us
  • Advertising & Sponsorship
  • Expert Panel
  • Permissions
  • Whitelist Emails
  • Press release policy
  • Accessibility

Contact

Contact Us

Office info

Neuro Central is powered by Taylor & Francis Group

Neuro Central, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2026 Neuro Central